Moving Forward after Privacy Shield’s Invalidation

Moving Forward after Privacy Shield’s Invalidation

On July 16, the Court of Justice of the European Union (“CJEU”) invalidated the Privacy Shield, one of the primary mechanisms used by companies to lawfully transfer personal data outside of the European Union under the GDPR. Despite a prior adequacy determination in 2016, the CJEU found that shortcomings in the Privacy Shield, particularly U.S. security and surveillance laws and an ineffective Ombudsperson program, resulted in a failure to provide essentially equivalent protections to those afforded to individuals within the European Union.

read more
Why Privacy & Consent Will Remain a Central Hurdle to Health Info Exchange Despite the Info Blocking Rule

Why Privacy & Consent Will Remain a Central Hurdle to Health Info Exchange Despite the Info Blocking Rule

Under the Privacy Exception, an Actor is permitted to not fulfill a request received to access, exchange, or use EHI to protect an individual’s privacy. The sub-exception for a “precondition-not-satisfied” will continue to put state laws governing privacy and consent at the center of decisions about whether EHI will be shared with third parties. Healthcare providers and HIEs/HINs especially will need to ensure that they have identified and analyzed each legal precondition to the release of EHI that is applicable to the particular type of entity and type of information that is implicated.

read more
Summary List of COVID19-related Federal Actions Relevant to Healthcare

Summary List of COVID19-related Federal Actions Relevant to Healthcare

As efforts at the federal and individual states level evolve every day at almost a breakneck pace to address challenges and needs related to the COVID-19 outbreak, here is a running list of some of the top actions taken at the federal level that we thought would be helpful to the healthcare industry (Caveat, this is not an exhaustive list):  [updated: July, 28, 2021]

read more

Archives